Orexin-A (Human)

Code:
4346-s
Name:
Orexin-A (Human)
Pyr-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2 (Disulfide bonds between Cys6-Cys12 and Cys7-Cys14)
(M.W. 3561.1) C152H243N47O44S4
Appetite-Boosting Peptide/Sleep-Wakefulness State Regulator
Package Price(Yen) Availability Quantity  
Vial 0.1 mg 20,000 Ships within
1-3 business days

main

Purity:
≧99.0% (HPLC)
Other Name:
Orexin A (human, bovine, canine, mouse, ovine, porcine, rat)
Hypocretin-1 (human, bovine, canine, mouse, ovine, porcine, rat)
オレキシンA ヒト, ラット, マウス
ヒポクレチン1
Storage:
-20 ℃
Source:
Rat, Mouse, Bovine
Production:
Synthetic Product

more information

CAS Registry Number:
205640-90-0
Category:
Biologically Active Peptides

reference

  1. T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R.M. Chemelli, H. Tanaka, S.C. Williams, J.A. Richardson, G.P. Kozlowski, S. Wilson, J.R.S. Arch, R.E. Buckingham, A.C. Haynes, S.A. Carr, R.S. Annan, D.E. McNulty, W.-S. Liu, J.A. Terrett, N.A. Elshourbagy, D.J. Bergsma, and M. Yanagisawa, Cell, 92, 573 (1998). (Original)
  2. L. de Lecea, T.S. Kilduff, C. Peyron, X.-B. Gao, P.E. Foye, P.E. Danielson, C. Fukuhara, E.L.F. Battenberg, V.T. Gautvik, F.S. Bartlett II, W.N. Frankel, A.N. van den Pol, F.E. Bloom, K.M. Gautvik, and J.G. Sutcliffe, Proc. Natl. Acad. Sci. USA, 95, 322 (1998). (cDNA; Same Sequence [Hypocretin])
  3. N. Takahashi, T. Okumura, H. Yamada, and Y. Kohgo, Biochem. Biophys. Res. Commun., 254, 623 (1999). (Pharmacol.)
  4. T. Ida, K. Nakahara, T. Murakami, R. Hanada, M. Nakazato, and N. Murakami, Biochem. Biophys. Res. Commun., 270, 318 (2000). (Pharmacol.)
  5. T. Sakurai, Regul. Pept., 85, 25 (1999). (Review)
  6. J.M. Siegel, Cell, 98, 409 (1999). (Review)
  7. L. De Lecea and J.G. Sutcliffe, Cell. Mol. Life Sci., 56, 473 (1999). (Review)
  8. R.J. Rodgers, Y. Ishii, J.C.G. Halford, and J.E. Blundell,, Neuropeptides, 36, 303 (2002). (Review)
  9. N. Tsujino and T. Sakurai, Pharmacol. Rev., 61, 162 (2009). (Review)
  10. M. Mieda and T. Sakurai, CNS Neurol. Disord. Drug Targets, 8, 281 (2009). (Review)

他の製品を検索する
商品へのこだわり
当社の技術


Scroll to top